Comparing the Effectiveness of MRI-Guided Versus Ultrasound-Guided Biopsies in the Detection of Prostate Cancer
dc.contributor.advisor | Nabi, Ghulam | |
dc.contributor.author | Alrashidi, Muteb | |
dc.date.accessioned | 2023-12-04T09:57:01Z | |
dc.date.available | 2023-12-04T09:57:01Z | |
dc.date.issued | 2023-11-23 | |
dc.description.abstract | Objective: Through a comprehensive systematic review and meta-analysis, this research sought to assess the diagnostic accuracy of MRI-guided prostate biopsies and ultrasound-guided prostate biopsies in the detection of prostate cancer. The research questions examined whether MRI-guided targeted biopsies improve detection of clinically significant prostate cancer (csPCa) and overall prostate cancer in comparison to ultrasound-guided biopsies. Methods: A comprehensive literature search was designed and conducted across multiple databases up to April 10, 2023, to identify relevant randomised controlled trials (RCTs) published between 2019 and 2023. RCTs comparing MRI-guided targeted biopsy to ultrasound-guided systematic or cognitive biopsy were included. Outcomes analysed were rates of csPCa detection and overall prostate cancer detection. The calculation of pooled odds ratios was performed using fixed-effects models for data that showed homogeneity and random-effects models for data that exhibited heterogeneity. The assessment of bias was conducted via the Cochrane RoB 2.0 tool. Results: Five RCTs with 1590 participants were included. A meta-analysis of three studies (n = 654) found MRI-guided biopsy significantly increased overall prostate cancer detection compared to ultrasound-guided biopsy (OR 1.93, 95% CI 1.40–2.68, p<0.0001). However, for csPCa detection specifically, MRI-guided biopsy showed a non-significant improvement over ultrasound-guided biopsy (OR 1.72, 95% CI 0.99–3.00, p = 0.06) based on three studies. Significant heterogeneity was present for csPCa detection (I² = 56%). Conclusion: MRI-guided targeted biopsy appears to improve overall prostate cancer detection versus ultrasound-guided approaches. However, evidence remains inconclusive regarding its advantages for detecting clinically significant prostate cancer specifically. Additional high-quality RCTs are needed to clarify the comparative accuracy of these biopsy techniques for csPCa detection. | |
dc.format.extent | 38 | |
dc.identifier.uri | https://hdl.handle.net/20.500.14154/70047 | |
dc.language.iso | en | |
dc.publisher | Saudi Digital Library | |
dc.subject | prostate cancer | |
dc.subject | prostate biopsy | |
dc.subject | MRI-guided biopsy | |
dc.subject | ultrasound-guided biopsy | |
dc.subject | systematic biopsy | |
dc.subject | targeted biopsy | |
dc.subject | detection rate | |
dc.subject | diagnostic accuracy | |
dc.subject | meta-analysis. | |
dc.title | Comparing the Effectiveness of MRI-Guided Versus Ultrasound-Guided Biopsies in the Detection of Prostate Cancer | |
dc.type | Thesis | |
sdl.degree.department | Medicine | |
sdl.degree.discipline | Imaging Science and Technology | |
sdl.degree.grantor | University of Dundee | |
sdl.degree.name | Master of Science |